Stem cell transplants and survivorship

Survivorship

Lucie Turcotte, M.D., M.P.H., recipient of the Cancer Detection, Treatment, and Survivorship Award will use Masonic funds to lay the foundation for a study on unique mechanisms of metabolic syndrome in pediatric cancer survivors.

The term "metabolic syndrome" describes a group of cardiovascular, renal, metabolic, prothrombotic, and inflammatory abnormalities that can individually or interdependently lead to cardiovascular disease.

Turcotte (at left in photo) and her team hope to look at the health of adolescent and young adult survivors of childhood cancer who received hematopoietic stem cell transplants and, specifically, how their immune systems may have contributed to the development of metabolic syndrome.

“Minnesota Masonic Charities has been instrumental in helping me launch not only this study, but others as well. The financial support is imperative for early-stage investigators like myself. I am incredibly appreciative of their support for childhood cancer research.” — Lucie Turcotte, M.D., M.P.H.

The first step is to find participants from a demographic of survivors, who are often difficult to recruit due to responsibilities such as school, family, and work. The team is working to identify strategies that make participation easier and exploring whether a large-scale study is feasible.

Related

Anne Blaes
While chemotherapy drugs can slow or stop the growth of cancer, they can also cause adverse health impacts in cancer survivors.
Beshay Zordoky
While advanced therapies have improved cancer survival rates, many of these medications can lead to cardiovascular disease later in life.